CPhI Japan will be held online from April 1 to 30, and an offline large-scale physical exhibition will be held at Tokyo Grand View Complex from April 14 to 16, 2021.
CPhI Japan's CPhI zone has imported more than 50% of Japan's APIs to Japan for generic drug production, which provides a huge opportunity for suppliers of raw materials and manufacturing solutions to showcase their products and services to leading decision makers in the region.
CPhI Japan Connect is a virtual platform that allows professionals from all over the world to experience CPhI Japan wherever they are.
Attendees can log in by product, department or company name and search for companies you are interested in, contact them to chat, and schedule online video conferences.
In addition to large users of cyclodextrin in Japan, Astellas, Otsukaés Daichii Sankyo, FujiFilm Wako, Daito, Sumitomo, Ajinomoto and other large pharmacies also include Sanofi. Manufacturers such as Dr. Reddy, Cadila Healthcare from India, Sinochem, Sinopharm and General Motors from China will also participate.
As a well-known manufacturer of pharmaceutical cyclodextrins excipients, Zhiyuan Biotech has more than ten years of professional research and development and production of medicinal betadex sulfobutyl ether sodium, hydroxypropyl beta cyclodextrin, methyl beta cyclodextrin, and will share the whole process with you of this CPhI grand exhibition.
For more information about cyclodextrin that you are interested in, please contact:
Tel/Whatsapp: +86 156 2892 7619